12:00 AM
 | 
Sep 30, 2013
 |  BC Week In Review  |  Company News  |  Deals

Activiomics, Kyowa Hakko Kirin deal

Activiomics extended a 2012 deal with Kyowa under which Activiomics is using its Targeted In-depth Quantification of Cell Signaling (TIQUAS) phosphoproteomics platform to identify...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >